Bio-Rad Laboratories (BIO) Capital Expenditures Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -6.49% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | -0.41% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -5.23% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -7.41% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -7.83% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -2.61% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -13.49% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 60.17% |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | 7.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.61% |
| Mar 31, 2026 | -5.66% |
| Dec 31, 2025 | 9.57% |
| Sep 30, 2025 | 4.76% |
| Jun 30, 2025 | 38.15% |
| Mar 31, 2025 | 1.31% |
| Dec 31, 2024 | -8.60% |
| Sep 30, 2024 | 5.10% |
| Jun 30, 2024 | 21.84% |
| Mar 31, 2024 | 27.17% |
| Dec 31, 2023 | -4.73% |
| Sep 30, 2023 | 30.18% |
| Jun 30, 2023 | 24.12% |
| Mar 31, 2023 | 18.28% |
| Dec 31, 2022 | 17.25% |
| Sep 30, 2022 | -3.92% |
| Jun 30, 2022 | -7.94% |
| Mar 31, 2022 | 11.87% |
| Dec 31, 2021 | 1.41% |
| Sep 30, 2021 | 16.23% |